BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16308711)

  • 1. [Diagnostics and treatment of prostate cancer after kidney transplantation].
    Wicht A; Hamza A; Loertzer H; Dietl M; Heynemann H; Fornara P
    Urologe A; 2006 Jan; 45(1):32-7. PubMed ID: 16308711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer.
    Aminsharifi A; Simon R; Polascik TJ; Robertson CN; Sudan DL; Collins BH; Moul JW
    J Urol; 2019 Sep; 202(3):469-474. PubMed ID: 30835631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-risk Prostate Cancer Prior to or After Kidney Transplantation.
    Stöckle M; Junker K; Fornara P
    Eur Urol Focus; 2018 Mar; 4(2):148-152. PubMed ID: 30005996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer screening and treatment in the transplant population: current status and recommendations.
    Breyer BN; Whitson JM; Freise CE; Meng MV
    J Urol; 2009 May; 181(5):2018-25; discussion 2025-6. PubMed ID: 19286214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urological complications after kidney transplantation].
    Burmeister D; Noster M; Kram W; Kundt G; Seiter H
    Urologe A; 2006 Jan; 45(1):25-31. PubMed ID: 16292481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatectomy for localized prostate cancer to prepare for renal transplantation in end-stage renal disease patients.
    Tillou X; Chahwan C; Le Gal S; Bensadoun H; Doerfler A
    Ann Transplant; 2014 Nov; 19():569-75. PubMed ID: 25374252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of prostate cancers in renal-transplant recipients.
    Cormier L; Lechevallier E; Barrou B; Benoit G; Bensadoun H; Boudjema K; Descottes JL; Doré B; Guy L; Malavaud B; Martin X; Patard JJ; Petit J; Salomon L
    Transplantation; 2003 Jan; 75(2):237-9. PubMed ID: 12548131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cancer in kidney transplantation waiting list patients: a single center experience.
    Mosconi G; Stalteri L; Centofanti F; Capelli I; Carretta E; Persici E; Ubaldi G; Battaglino G; Raimondi C; Scolari MP; Stefoni S
    Transplant Proc; 2011 May; 43(4):1003-5. PubMed ID: 21620036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer in renal transplant recipients.
    Sherer BA; Warrior K; Godlewski K; Hertl M; Olaitan O; Nehra A; Deane LA
    Int Braz J Urol; 2017; 43(6):1021-1032. PubMed ID: 28338305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Localized Prostate cancer in candidates for renal transplantation and recipients of a kidney transplant: The French Guidelines from CTAFU].
    Culty T; Goujon A; Defortescu G; Bessede T; Kleinclauss F; Boissier R; Drouin S; Branchereau J; Doerfler A; Prudhomme T; Matillon X; Verhoest G; Tillou X; Ploussard G; Rozet F; Méjean A; Timsit MO
    Prog Urol; 2021 Jan; 31(1):4-17. PubMed ID: 33423746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Access to the waiting list and renal transplantation].
    Hourmant M; de Cornelissen F; Brunet P; Pavaday K; Assogba F; Couchoud C; Jacquelinet C;
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S139-66. PubMed ID: 24119579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient comorbidity is associated with conservative treatment of localized prostate cancer.
    Jespersen CG; Nørgaard M; Jacobsen JB; Borre M
    Scand J Urol; 2015; 49(5):366-70. PubMed ID: 25903072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of localized prostate cancer by retropubic radical prostatectomy in patients after renal transplantation.
    Hoda MR; Hamza A; Greco F; Wagner S; Reichelt O; Heynemann H; Fischer K; Fornara P
    Nephrol Dial Transplant; 2010 Oct; 25(10):3416-20. PubMed ID: 20388632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancies after renal transplantation in southern Taiwan: experience in one centre.
    Feng WW; Wang TN; Chen HC; Ho JC; Ko YC
    BJU Int; 2007 Apr; 99(4):825-9. PubMed ID: 17155978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urological de novo malignancy after kidney transplantation: a case for the urologist.
    Melchior S; Franzaring L; Shardan A; Schwenke C; Plümpe A; Schnell R; Dreikorn K
    J Urol; 2011 Feb; 185(2):428-32. PubMed ID: 21167532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthotopic kidney transplantation: an alternative surgical technique in selected patients.
    Musquera M; Peri LL; Alvarez-Vijande R; Oppenheimer F; Gil-Vernet JM; Alcaraz A
    Eur Urol; 2010 Dec; 58(6):927-33. PubMed ID: 20888120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall outcomes in kidney transplant recipients with hepatitis C in a district hospital in Camagüey, Cuba.
    Millet Torres D; Curbelo Rodríguez L; Ávila Riopedre F; Benítez Méndez M; Prieto García F
    Nefrologia; 2015; 35(5):509-11. PubMed ID: 26306958
    [No Abstract]   [Full Text] [Related]  

  • 19. Is localized prostate cancer an obstacle for an immediate consideration for renal transplantation? A case report.
    Kocak B; Bilen CY; Dilek M; Adibelli Z; Akpolat T; Sarikaya S
    Transplant Proc; 2009 Jun; 41(5):1961-2. PubMed ID: 19545767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancies after renal transplantation in Taiwan: a nationwide population-based study.
    Li WH; Chen YJ; Tseng WC; Lin MW; Chen TJ; Chu SY; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
    Nephrol Dial Transplant; 2012 Feb; 27(2):833-9. PubMed ID: 21633099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.